Stimwave Receives FDA Clearance for World’s First Injectable Wireless

by Stimwave Technologies

Stimwave Technologies Incorporated, a medical device manufacturer and independent research institute headquartered in Miami Beach, Fla., has received FDA 510(k) clearance to market the world’s first wireless, micro-technology neuromodulation device for relief of chronic back and leg pain.  Currently being marketed throughout Europe, Stimwave’s revolutionary electroceutical device will be commercially available in the U.S. as of January 2015.

See the full article here.

Go to kBLASTER for FDA 510(k) predicate search with effective result management to build your successful 510(k) clearance strategy.